Pdt Partners, LLC Abb Vie Inc. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.34 Million - $1.55 Million	10,000 New	10,000 $1.49 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $285,464 - $327,409	2,127 New	2,127 $285,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $30.6 Million - $41 Million	-417,300 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $20.6 Million - $31.3 Million	319,900 Added 328.44%	417,300 $31.8 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $25.9 Million - $32.5 Million	-359,684 Reduced 78.69%	97,400 $8.62 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $47.1 Million - $56.7 Million	-748,167 Reduced 62.08%	457,084 $34.6 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $79.2 Million - $101 Million	1,205,251 New	1,205,251 $87.6 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.